Bill Hwang was heavy in Chinese Tech
The Bill Hwang (Archegos) situation may start a deleveraging of Chinese Tech stocks - including NIO , like what happened to VIAC and DISCA.
Archegos is also being reported to have massive amounts of Chinese Tech holdings. If so, you will potentially see large block sales take place.
Goldman, Morgan Stanley and Credit Suisse are the PBs for Archegos.
Nomura Holdings is now reporting 2 billion in loses related to the situation, and is reported to have heavy Chinese tech holdings.
If the investment banks start to restrict margin, you will have a massive deleveraging of tech.
Also, we will see this week if there will be a cascading affect and if other Hedge Funds will get margin called and forced deleveraged.
Chart support lines will have to be completely re-written if deleveraging occurs, as the liquidity in tech would be pulled.
This is what a lot of us have been discussing, the massive price runups being caused by Hedge Funds and extremely high margin usage.
There are a lot of unknowns at this point. This will be an interesting week, let's see how it unfolds, and do your own research.
Archegos is also being reported to have massive amounts of Chinese Tech holdings. If so, you will potentially see large block sales take place.
Goldman, Morgan Stanley and Credit Suisse are the PBs for Archegos.
Nomura Holdings is now reporting 2 billion in loses related to the situation, and is reported to have heavy Chinese tech holdings.
If the investment banks start to restrict margin, you will have a massive deleveraging of tech.
Also, we will see this week if there will be a cascading affect and if other Hedge Funds will get margin called and forced deleveraged.
Chart support lines will have to be completely re-written if deleveraging occurs, as the liquidity in tech would be pulled.
This is what a lot of us have been discussing, the massive price runups being caused by Hedge Funds and extremely high margin usage.
There are a lot of unknowns at this point. This will be an interesting week, let's see how it unfolds, and do your own research.
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.